glp-1 news october 1 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Pipeline Update: August 2025

"I got burned with fake reta again," is a common refrain in TikTok videos and Reddit forums

Please provide a link back to this page

They act on different appetite pathways cagrilintide is a long-acting amylin analog, while tirzepatide is a dual GIP/GLP-1 receptor agonist which is the theoretical reason researchers discuss pairing them

Analysts have previously expressed concerns that Omada isn't yet profitable (though the company narrowed its losses to about $3.2 million in the third quarter) and faces an increasingly competitive digital health market as it looks to compete with dozens of online GLP-1 prescribers